Announcements | Director's Message from Helene M. Langevin, M.D. February 2, 2022 Our first National Advisory Council for Complementary and Integrative Health meeting of the year was a terrific opportunity to update our stakeholders on the National Center for Complementary and Integrative Healths (NCCIHs) current priorities and whats ahead in 2022. It was a robust conversation and, in particular, a good chance to spotlight efforts that will help us advance research on pain, a long-standing priority for NCCIH that is deeply embedded throughout ourstrategic plan. |
| January 2022 Clinical Digest Benign prostatic hyperplasia (BPH) can lead to obstructive and bothersome lower urinary tract symptoms. Prostate gland enlargement can block the flow of urine out of the bladder, which can cause bladder, urinary tract, or kidney problems. The use of some complementary health approaches such as phytotherapy for the treatment of lower urinary tract symptoms is common. Although there is limited evidence that some phytotherapeutic agents may help improve symptoms related to BPH over the short term, most of the trials conducted have been small in size, of short duration, and used varied doses and preparations. |
Resources for Researchers HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes & Cells (U19 Clinical Trial Not Allowed) HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed) Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations to Improve the AI/ML-Readiness of NIH-Supported Data Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship Notice of Special Interest (NOSI): Administrative Supplements for Advancing the Ethical Development and Use of AI/ML in Biomedical and Behavioral Sciences PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) Request for Information (RFI): Research Challenges and Needs in the Biobehavioral Mechanisms of Aggression Highlighted Funding Opportunities Request for Information (RFI): Research Challenges and Needs in the Biobehavioral Mechanisms of Aggression(NOT-OD-22-041)
The deadline for this RFI has been extended to March 1, 2022. Diversity Resources Inviting Comments and Suggestions on the Draft NIH Chief Officer for Scientific Workforce Diversity Strategic Plan for FYs 2022-2026 (NOT-OD-22-054)
The deadline for comments is February 10, 2022.
Request for Information (RFI): Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan for Diversity, Equity, Inclusion, and Accessibility (NOT-OD-22-061)
The deadline for comments is April 3, 2022. Upcoming Events 2nd Thursday of the month, 3:00 p.m.-4:15 p.m. ET The NIH Pain Consortiums Grant Mechanism Webinar Series is designed for investigators at different stages of their careers, highlights specific types of funding opportunities and gives details on the nuts and bolts of planning and submitting applications. The webinars are free, but pleaseregister in advance.Visit the NIH Pain Consortium website to view video recordings of past webinars and learn about the dates and times of future webinars. Upcoming topics include: How to build a budget (February 2022) Programs to support technology development (March 2022) Clinical and translational science awards and patient engagement studios (April 2022) NIH data policy and data harmonization (May 2022) Clinical trial oversight (June 2022)
February 10, 2022, 3:00 p.m.-4:40 p.m. ET This is the next NIH Pain Consortium webinar in a series on NIH grant mechanisms in pain research across career stages (training, transition and independent stages). This session will feature an experienced principal investigator share their perspective on budget-development, guidance from a university administrator, and NIH grants management specialists explaining what they look for in a prospective budget, and a question and answer session. There is no cost for these webinars, but attendees must register in advance. Register now. Preclinical Evaluation of Interactions Between Dietary Botanicals and Drugs March 30, 2022, 11:00 a.m. ET The speaker will be Cassandra L. Quave, Ph.D.Emory College of Arts and Sciences, Center for the Study of Human Health, and Curator of the Herbarium, Atlanta, GA (and NCCIH grantee). If you would like to view this lecture and receive information about the ODS Seminar Series,please email the NIH Office of Dietary Supplements at[email protected]. April 7-10, 2022; Wolf TrapNational Park for the Performing Arts (Vienna, VA) This international interdisciplinary workshop is focused on the theme of creative movements and the brain. The in-person workshop will take place at the Wolf Trap National Park for the Performing Arts. The planning committee invites an exceptionally wide range of scientists, engineers, and clinicians to exchange ideas with and to integrate knowledge and experience among creative movement professionals and other performing artists. The primary goals of the event are to encourage all participants to reach beyond the confines of their expertise to explore the science of learning to move, how the creative process is manifested in the brain, and how it can be harnessed to enhance health and the quality of life. The workshop will include 3 days of scientific presentations and 1 final day of educational outreach and performances. Presentations will include demonstrations within sessions. | April 26-27, 2022, 10:00 a.m.-5:30 p.m. ET Probiotic interventions may potentially offer beneficial effects, such as alleviation of gastrointestinal symptoms; strengthening of the immune system; protection against infectious diseases; prevention of metabolic disorders; improved mental health; promotion of early development; and general well-being. However, one major challenge in assessing the effects of probiotic interventions has been the inconsistent results of clinical trials. We now have a better understanding of some of the biological and behavioral factors that might contribute to inconsistent outcomes from probiotic interventions (e.g., differences in gut microbiota, diet, age, and lifestyle). |
|
